knowledge -WSS

knowledge

author：knowledge 2025-10-02 17:22:30 - browse：874

New Sanofi Genzyme president Bill Sibold is the first person without any ties to Henri Termeer (inset) to lead the company. Jonathan Wiggs/Globe staff

CAMBRIDGE, Mass. — When drug giant Sanofi restructured its global business two years ago, its Genzyme division got a new name, Sanofi Genzyme, explicitly tying it to the French parent company. It also got new responsibilities and a larger “specialty care” portfolio covering everything from enzyme replacement to cancer and multiple sclerosis drugs.

Last week, Sanofi Genzyme — still the largest Massachusetts biotech, with about 5,000 workers — also got a new president, Bill Sibold. He’s the first one without any ties to the old Genzyme, an independent company that pioneered the rare-disease business model and catalyzed the local life sciences boom before accepting Sanofi’s $20.1 billion takeover offer in 2011.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medical records are filled with copy
Next article： Readout Newsletter: Sanofi, Novavax, Maze x Shionogi news

leisure time

WSS

Telehealth startups turn to complex chronic diseases

Study: Spinal cord stimulation helps patients with paralysis walk again

Meadows told special counsel he could not recall Trump ever declassifying Mar

Intellia plays down concerns on accidental germline transmission

Google says AlphaFold 3 can map a vast universe of biomolecules

How the first Native Hawaiian psychiatrist helped diversify medicine

hotspot

knowledge

leisure time

Wildfire smoke exposes gaps in outdoor worker protections

Google says AlphaFold 3 can map a vast universe of biomolecules

Sports medicine is finally prioritizing gender equality

How to improve immunocompromised access to mAb treatments

Sports medicine is finally prioritizing gender equality

Medicare says breakthrough device reimbursement rule to come by summer

Virginia high school admissions case could be legal follow

Telehealth startups turn to complex chronic diseases

After affirmative action ruling, medical educators look to 'holistic review'

Study: AI not yet building 'n

focus

Republicans love RFK Jr. What's that tell us about health in 2024?

Listen: Vivek Ramaswamy's star turn & leaky drug data

Brain worms: The science behind RFK Jr.'s parasitic infection

FDA greenlights medical device to combat bladder issues

People can get long Covid without testing positive for virus: Study

Making AI in medicine accessible to smaller, and rural hospitals

leisure time

Wikipedia

focus

entertainment